The Boston-based biotech is axing Phase II plans for its only clinical-stage asset, in a bid to maximise shareholder value.

Helex has raised $3.5m in a seed funding round spearheaded by pi Ventures to advance non-viral gene therapies for kidney ...

Mounjaro generated sales of $6.5bn in Q3 2025, up 109% from the same period in 2024. Zepbound exhibited even higher growth – ...

Epioxa by Glaukos Corp received US Food and Drug Administration (FDA) approval on 20 October as the first and only ...

As healthcare systems work towards new sustainability goals, medical textiles have become a key focus for innovation.

Swiss-based Debiopharm has formed a research partnership with South Korea-based AI drug discovery company NetTargets.

MSD has received US FDA approval for an updated indication of Winrevair by injection to treat adults with pulmonary arterial ...

Dewpoint Therapeutics has received the US Food and Drug Administration’s (FDA) orphan drug designation (ODD) for DPTX3186, a ...

The FDA's draft guidance is supposed to cut the cost and time-associated burden of biosimilar development, despite a mixed ...

GSK has acquired the rights to Syndivia’s preclinical antibody drug conjugate (ADC), which is in development for prostate ...

Novartis has signed an agreement for the acquisition of all the outstanding shares of US-based Avidity Biosciences.